USA Healthcare Updates

  The global   sedation in ICU setting market size   was valued at USD 2385.3 Million in 2018 and is projected to reach USD 3688.2 Million by 2026, exhibiting a CAGR of 5.7% in the forecast period (2022-2026) Introduction Patients in intensive care units (ICUs) are generally sedated for prolonged periods. Over-sedation and under-sedation both have negative effects on patient safety and resource use. We conducted a systematic review of the literature in order to establish the incidence of sub-optimal sedation (both over- and under-sedation) in ICUs. The majority of mechanically ventilated patients within the intensive care unit (ICU) receive sedative drugs. Sedation is administered to ensure patient comfort, reduce anxiety, and facilitate treatments. Optimising sedation management is recognised as important in improving patient outcomes [1]. Under-sedated patients may become agitated and distressed and are at risk of adverse events such as extubation [2–4], whereas over-se...

  The   Netherland home healthcare market size   stood at USD 570.0 Million in 2018 and is projected to reach USD 1,013.1 Million by 2026, exhibiting a CAGR of 7.6% in the forecast period (2022-2026) Supportive Government Acts & Policies Along with Increasing Healthcare Expenditure on Elderly Population Likely to Drive the Netherland Home Healthcare Market During the Forecast Period The Health Insurance Act and the Long- Term Care Act amongst others are the basic foundation of the Netherlands overall healthcare system. The Netherlands government allocates heavy budgets for the implementation of these two important acts each year. The Health Insurance Act deals with hospital care while that of Long-Term Care Act deals with the other types of care, which includes, elderly care, home healthcare and others. Increasing prevalence of chronic conditions and supported by favourable government policies are expected to boost the adoption of home healthcare products in the Nethe...

  The global   neurodegenerative diseases drugs market   size was valued at USD 35,497.3 Million in 2018, is projected to reach USD 62,786.2 Million by the end of 2026, exhibiting a CAGR of 7.2%. Classification of neurodegenerative diseases The number of neurodegenerative diseases is currently estimated to be a few hundred, and, among these, many appear to overlap with one another clinically and pathologically, rendering their practical classification quite challenging. The issue is further complicated by the fact that, in diseases such as multisystem atrophy in which several areas of the brain are affected, different combinations of lesions can give rise to different clinical pictures (2). Furthermore, the same neurodegenerative process, especially at the beginning, can affect different areas of the brain, making a given disease appear very different from a symptomatic standpoint. Despite these difficulties, the most popular categorization of neurodegenerative disorders ...

  The global   non small cell lung cancer (NSCLC) therapeutics market   size was valued at USD 16,011.7 Million in 2018 and is projected to reach USD 43,713.1 Million by the end of 2026, exhibiting a CAGR of 13.4% in the forecast period (2019-2026). Research led by UT Southwestern scientists suggests that an investigational drug could restore the ability of some non-small cell lung cancers (NSCLCs) to respond to an immune checkpoint blockade (ICB), a therapy that harnesses the immune system to fight malignant tumors. The findings, derived from a preclinical lab model and published in  Cell Reports Medicine , could lead to more effective treatments for this subset of NSCLCs. Get a Sample Copy of the Report at –  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100484 “These results provide hope that we can significantly enhance the efficacy of immune checkpoint blockade in non-small cell lung cancer patients for whom immunotherapi...

  The global   lung cancer therapeutics market size   was valued at USD 18,327.6 Million in 2018 and is projected to reach USD 48,725.9 Million by 2026, exhibiting a CAGR of 13.0% in the forecast period (2019-2026) The American Cancer Society reports a decreased death rate but continued preventable cancer deaths as well as racial and socioeconomic disparities in cancer care.   A little over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022, according to the 2022  Cancer Facts & Figures  report from the American Cancer Society (ACS). About 609,360 deaths from cancer are expected this year, equivalent to 1670 deaths per day. Estimates were based on reported cancer incidents and mortality through 2018 and 2019 and do not include the unknown impact of COVID-19. However, the ACS suggests that disruption of health services from COVID-19 has resulted in millions of missed or postponed appointments, screenings...

  The global   active wound care market size   was valued at USD 1,361.7 Million in 2017 and projected to reach USD 2,039.9 Million by 2025, exhibiting a CAGR of 5.2% in the forecast period. Transforming wound care through science   Your goal is to protect and support your patient along their surgical journey, hospital stay or clinic visit. We are here to help address your challenges with leading innovations in negative pressure wound therapy (NPWT), surgical incision management, infection prevention, advanced wound care and skin integrity to help meet the needs of the people you care for every day. No matter your patients’ needs, we are with you and your team every step of the way. We provide you with innovative products that are rooted in clinical evidence, helping you accelerate patient healing and drive more effective outcomes.  Get a Sample Copy of the Report at –  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100172 This multidisc...

Global   Breast Cancer Therapeutics Market Size  research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. Nearly 2 Million US New Cancer Cases Expected in 2022 The American Cancer Society reports a decreased death rate but continued preventable cancer deaths as well as racial and socioeconomic disparities in cancer care. A little over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022, according to the 2022  Cancer Facts & Figures  report from the American Cancer Society (ACS). About 609,360 deaths from cancer are expected this year, equivalent to 1670 deaths per day. Estimates were based on reported cancer incidents and mortality through 2018 and 2019 and do not include the unknown impact of COVID-19. However, the ACS suggests that disruption of health servi...